The Trump administration will accelerate research and approval of psychedelic treatments to help Americans combat mental illness.
President Donald Trump signed an executive order on April 18 aimed at establishing a pathway to give people easier access to psychedelic drugs, including controversial ibogaine compounds.
The Epoch Times asked readers to weigh in on whether Trump’s order will help combat the mental health crisis in the United States, and 546 responded.
Mental Health Crisis
Nearly one in five adults in the United States are affected by a mental illness each year, according to data from the National Alliance on Mental Illness.
Americans have a plethora of options to treat mental health issues, such as therapy, exercise, and prescribed medicines, but some have dabbled with controversial—and illegal—fixes for their condition….